Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?
Goldberg H, Cheung DC, Chandrasekar T, Klaassen Z, Wallis CJD, Kulkarni GS, Sayyid R, Evans A, Masoomian M, Bapat B, van der Kwast T, Hamilton RJ, Zlotta A, Fleshner N. Goldberg H, et al. Among authors: cheung dc. Can Urol Assoc J. 2019 Sep;13(9):E292-E299. doi: 10.5489/cuaj.5595. Can Urol Assoc J. 2019. PMID: 30763230 Free PMC article.
Canadian Update on Surgical Procedures (CUSP) Urology Group consensus for intraoperative hemostasis during minimally invasive partial nephrectomy.
Cheung DC, Wallis CJD, Possee S, Tajzler C, Anidjar M, Barrett K, Deklaj T, Drachenberg DE, Evans H, French C, Gotto G, Izard J, Jain U, Kawakami J, Kulkarni GS, Lee J, McCracken J, McGregor T, Richard PO, Rowe NE, Sabbagh R, St Martin B, Tatzel S, Touma N, Widmer H, Wiesenthal J, Yang B, Zorn KC, Kapoor A, Finelli A, Satkunasivam R; Canadian Update on Surgical Procedures (CUSP) Urology Group. Cheung DC, et al. Can Urol Assoc J. 2020 Sep;14(9):E387-E393. doi: 10.5489/cuaj.6579. Can Urol Assoc J. 2020. PMID: 32569571 Free PMC article.
A Population-based Study Comparing Outcomes for Patients With Metastatic Castrate Resistant Prostate Cancer Treated by Urologists or Medical Oncologists With First Line Abiraterone Acetate or Enzalutamide.
Woon DTS, Finelli A, Cheung DC, Martin LJ, Alibhai S, Wallis CJD, Diong C, Saskin R, Kulkarni G, Fleshner N. Woon DTS, et al. Among authors: cheung dc. Urology. 2021 Jul;153:147-155. doi: 10.1016/j.urology.2020.11.080. Epub 2021 Feb 13. Urology. 2021. PMID: 33592224
43 results